Search

everythinglearnresearchcommunity

for

Search:↓

Frontal fibrosing alopecia in men is often misdiagnosed and needs better diagnostic criteria and treatments.

Diagnosing and treating PCOS is complex due to differing criteria and requires a team approach.

Including ovarian morphology in diagnosis increases PCOS prevalence estimates, highlighting the need for standardized criteria.

Androgen measurements are mostly unnecessary for diagnosing PCOS, except in women with menstrual issues.

Melanoma patients can learn to check their skin, early balding in men may indicate similar risks as PCOS in women, certain criteria can help predict skin cancer behavior, small skin cancer may not need extra therapy after surgery, and sterile gloves don't reduce infection in minor surgeries.

Androgen levels do not determine the type of PCOS symptoms in young females.

Men with early-onset baldness have a higher chance of heart disease and clogged arteries.

PRP with microneedling works better than injection for hair loss treatment.

Taking 1 mg of finasteride daily can increase hair count and improve hair appearance, but it may have side effects on sexual function and a potential risk of prostate cancer. It may not be effective for postmenopausal women unless taken in higher doses.

At least 87% of Indian men experience hair loss, with type II being most common and severity increasing with age.

The TPAP method effectively categorizes androgenetic alopecia patients with high accuracy, but needs real-world validation.

Early-onset male baldness may increase the risk of metabolic syndrome.

Topical minoxidil and oral finasteride and dutasteride are the most effective treatments for male and female pattern hair loss, but study quality varies.

The research found no clear link between the severity of male baldness and the scalp examination findings in Indonesian men.

PCOS is a common condition in women that can lead to infertility and other health issues, and it's diagnosed by specific criteria with various treatment options available.

People with early-onset hair loss have higher risk of heart issues, so early screening is important.

AGA patients have higher rates of metabolic syndrome and carotid atheromatosis, suggesting early screening and prevention is important.

Too much male hormone is the main cause of Polycystic Ovary Syndrome.

Androgens cause skin issues like acne and hair growth in women, often due to PCOS, and can be treated with medication and lifestyle changes.

Hair thickness differences help diagnose hair loss severity.

Overweight women with PCOS are more likely to have excess male hormones.

Not enough evidence to support using platelet rich plasma for hair loss treatment.

New LPP subtype affects vellus hairs, mimics AGA, and needs biopsy for diagnosis.

Lower zinc levels may predict less effective hair loss treatment.

Topical minoxidil is effective and safe for hair regrowth in Middle Eastern men with early baldness, with better results in younger patients and certain types of baldness.

Biopsy can differentiate between alopecia areata and androgenic alopecia, and if more information is needed, testing for CD3 and CD8 can help.

Non-medical steroid use in gym-goers is risky and needs better prevention and care strategies.

Alcohol may slightly increase the risk of hair loss, but the link is uncertain.

Trichoscopy shows hair diameter variability, vellus hairs, and the peripilar sign are key indicators for diagnosing Androgenetic Alopecia.

Oral and topical finasteride are effective and safe for treating female hair loss.